Lipids & metabolic liver disease

Population‐based cohort validation and replication reveals limited generalizability of cluster‐based MASLD subtypes

Diabetes Obes MetabPublished Population-based cohort study

Authors' conclusion

The subtyping model demonstrated limited generalizability. Nonetheless, the consistent identification of broad cardiometabolic and liver-specific patterns suggests potential value for risk stratification, pending further validation.

Study context

Population
Participants with MASLD from NHANES III, nationally representative U.S. population
Participants
3,300 participants
Exposure
Cluster-based MASLD subtypes
Outcome
All-cause, cardiovascular-related and diabetes-related mortality across clusters
Methodological detailsvalidation and replication of a prior clustering model, Partitioning Around Medoids algorithm, Cox proportional hazards models accounting for complex survey design
  • Validation and replication of a prior clustering model
  • Partitioning Around Medoids algorithm
  • Cox proportional hazards models accounting for complex survey design

Main finding

As reported in the abstract

Mortality across clusters
  • Individual cluster assignments showed limited reproducibility between validation and replication analyses, although the overall clustering pattern was preserved
  • Cardiometabolic cluster consistently showed higher risks in both analyses
  • Liver-specific cluster showed no significant associations

Observational data: associations, not effects.

Original publication

Population‐based cohort validation and replication reveals limited generalizability of cluster‐based MASLD subtypes. Diabetes Obes Metab. Published 7 January 2026. doi:10.1111/dom.70448

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.